, , , , , , , , , , , , , , , , , , , , , ,

Researchers from Rutgers University and Dartmouth College’s combined efforts have result in an oral medication that seems to selectively kill the AIDS-causing, HIV-infected cells. This is a large leap in research, as previous treatment for AIDS and HIV-infected cells that would prevent the growth of the virus but were unable to kill it or cure it.

“The discovery raises the hope that HIV may not be able to develop resistance against this novel class of drugs,” said study co-author Paul Palumbo of Dartmouth’s Geisel School of Medicine. “It gives credence to the concept that like cancer cells, HIV-infected cells can be targeted and eliminated by a drug.”

Read the full story here.